Literature DB >> 4020783

Assessing the number of genital chlamydial infections in the United States.

F N Judson.   

Abstract

The prevalence and incidence of genital infections with Chlamydia trachomatis have not yet been determined for broadly based populations within the United States. Largely on the basis of results of prevalence studies from sexually transmitted disease clinics, it has been estimated that C. trachomatis infections are the most common of all sexually transmitted infections and may number 3-5 million cases annually. C. trachomatis isolation rates range from 50% to 80% in certain diseases known to be caused by Chlamydia and from 10% to 30% in sexually active female adolescents and approximately 5% in college women. Cheaper, more-sensitive and widely available diagnostic tests are necessary to adequately define the epidemiology of genital Chlamydia infections in the U.S.

Entities:  

Keywords:  Americas; Bacterial And Fungal Diseases; Barrier Methods; Condom; Contraception; Developed Countries; Developing Countries; Diseases; Evaluation; Evaluation Methodology; Family Planning; Incidence; Infections; Measurement; North America; Northern America; Prevalence; Reproductive Tract Infections; Research Methodology; Sexually Transmitted Diseases; United States; Vaginal Diaphragm

Mesh:

Year:  1985        PMID: 4020783

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  14 in total

1.  In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.

Authors:  L E Welsh; C A Gaydos; T C Quinn
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens.

Authors:  C A Gaydos; C A Reichart; J M Long; L E Welsh; T M Neumann; E W Hook; T C Quinn
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Comparison of clinical and epidemiological characteristics of pelvic inflammatory disease classified by endocervical cultures of Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  F N Judson; B G Tavelli
Journal:  Genitourin Med       Date:  1986-08

4.  The Hawaii Chlamydia Network Project: a successful program incorporating close intra-agency cooperation.

Authors:  A R Katz
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

5.  Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma.

Authors:  A Matsumoto; H Izutsu; N Miyashita; M Ohuchi
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Detection of Chlamydia trachomatis by isothermal ramification amplification method: a feasibility study.

Authors:  Wandi Zhang; Menashi Cohenford; Brian Lentrichia; Henry D Isenberg; Elkin Simson; Hengjin Li; Jizu Yi; David Y Zhang
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

7.  Treatment of Chlamydia trachomatis infections in pregnant women.

Authors:  J M Miller; D H Martin
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

8.  Improved isolation of Chlamydia trachomatis from a low-prevalence population by using polyethylene glycol.

Authors:  J P Gibson; R M Egerer; D L Wiedbrauk
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  Amplification of Chlamydia trachomatis DNA by ligase chain reaction.

Authors:  B J Dille; C C Butzen; L G Birkenmeyer
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

10.  Evaluation of chlamydiazyme enzyme immunoassay for detection of Chlamydia trachomatis in urine specimens from men.

Authors:  J M Ehret; J C Leszcynski; J M Douglas; S L Genova; M A Chernesky; J Moncada; J Schachter
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.